Details for 2019782800

Up to date per 01.04.2026

Actions

Title / Product Name

DOSIERSTRATEGIE, DIE DAS CYTOKIN-FREISETZUNGSSYNDROM FÜR CD3 / CD20-BISPECIFISCHE-ANTIKÖRPER VERMEIDET

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019782800

EP Publication Number

3844189

E-Number

1761426

Language

PCT Number

US19049027

Publication Date

07.07.2021 A

22.01.2025 B1

Registration Date

22.01.2025

AT Publication Date

15.02.2025

Application Date

30.08.2019

Registration Number

Priorities

31.08.2018

201862726137 P

30.11.2018

201862774019 P

13.06.2019

201962861100 P

IPC

C07K 16/28 20060101AFI20200306BHEP

Maximum Duration of Protection

30.08.2039

Owner

Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River Road Tarrytown, NY 10591US

Representative

Patentanwaltskanzlei Matschnig & Forsthuber OGBiberstraße 221010 WienAT

Inventor

BROWNSTEIN, Carrie12 W. 72nd Street, 16D New York, New York 10023US

LOWY, Israelc/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, New York 10591US

ADRIAENS, Lieve Lucillec/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, New York 10591US

Information about Fees